USFDA concludes inspection at Solara’s Ambernath facility

10 May 2025 Evaluate

US Food and Drug Administration (USFDA) has completed the inspection at Solara Active Pharma Science’s multi-product manufacturing facility at Ambernath, Maharashtra. The inspection established that the site is in an ‘Acceptable State of Compliance’ with Zero Form 483 inspectional observations from USFDA. The Agency with their designated investigator inspected the facility from May 5th to 9th 2025. Solara continues to stay focused on maintaining the highest level of compliance across its manufacturing facilities.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Solara Active Pharma Share Price

466.20 5.40 (1.17%)
05-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.90
Dr. Reddys Lab 1313.05
Cipla 1326.00
Zydus Lifesciences 914.45
Lupin 2332.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×